U.S. markets open in 9 hours 5 minutes
  • S&P Futures

    3,300.75
    +1.50 (+0.05%)
     
  • Dow Futures

    27,258.00
    +115.00 (+0.42%)
     
  • Nasdaq Futures

    11,113.00
    -36.50 (-0.33%)
     
  • Russell 2000 Futures

    1,489.50
    +0.70 (+0.05%)
     
  • Crude Oil

    39.55
    -0.05 (-0.13%)
     
  • Gold

    1,890.60
    -17.00 (-0.89%)
     
  • Silver

    23.81
    -0.72 (-2.93%)
     
  • EUR/USD

    1.1681
    -0.0029 (-0.25%)
     
  • 10-Yr Bond

    0.6640
    -0.0070 (-1.04%)
     
  • Vix

    26.86
    -0.92 (-3.31%)
     
  • GBP/USD

    1.2718
    -0.0018 (-0.14%)
     
  • USD/JPY

    105.0650
    +0.1410 (+0.13%)
     
  • BTC-USD

    10,492.69
    -49.06 (-0.47%)
     
  • CMC Crypto 200

    222.44
    +8.68 (+4.06%)
     
  • FTSE 100

    5,829.46
    +25.17 (+0.43%)
     
  • Nikkei 225

    23,277.06
    -83.24 (-0.36%)
     

Coronavirus Latest: Monday, September 14

According to a report from Reuters, AstraZeneca’s vaccine trial is to remain on hold in the United States until midweek, even though the company said it would be restarting. This comes as Pfizer CEO Bourla, claims that he is readying Pfizer for the end of year as he believes the U.S. government will make a push to make a vaccine publicly available. Yahoo Finance’s Anjalee Khemlani joins The Final Round to discuss the latest on the coronavirus.

Video Transcript

MYLES UDLAND: --in the program. All right. Let's turn our attention now to everything going on with the coronavirus. And we've heard now for several months that the end of this year would be a potential for some kind of vaccine to not only be approved but maybe get its way out into the public. And some of those headlines continue today. Anjalee Khemlani joins us for the latest on all of that, Anjalee.

ANJALEE KHEMLANI: Thanks, Myles. Yep, so reaffirming that message today we heard from Pfizer CEO saying about the same, that the vaccine is likely to be distributed to Americans by the end of this year. But we're still looking at what that timeline looks like in terms of actuality with Phase 3 of their trial reporting out by the end of October but not early enough by the end of October to be involved in the independent discussions about vaccine distribution.

So that's going to be an interesting timeline in just how close that gets to the end of October and possibly longer. Meanwhile, we know that AstraZeneca did resume its trial. We know it was on hold last week because a patient had an unexplained illness in the UK for Phase 3. And that triggered a sort of a hold globally for all trials. So right now, we're waiting on word on what happens with the US trials and whether or not those can continue this week.

ANJALEE KHEMLANI: All right. Anjalee Khemlani with all the latest going on on the coronavirus front. Anjalee, we'll talk to you later on.